Diffusion-weighted imaging (DWI) could help differentiate between benign and malignant tumors and predict tumor recurrence in breast cancer patients, according to research published Oct. 4 in Academic Radiology. The authors noted that DWI may also serve as a beneficial supplement to contrast-enhanced breast MRI.

More than 41 percent of women with dense breasts will choose to forgo supplemental breast MRI after receiving a negative mammography screening, according to a study recently published in Clinical Radiology.

A Pennsylvania woman was shocked when quoted $351 for a breast MRI from the Crozer-Keystone Health System, before being billed $4,650 for the exam.  

For the last 10 years, researchers from the University of Texas MD Anderson Cancer Center have been compiling examples of when breast MRI may be helpful for male patients, according to a study published online Jan. 10 in Diagnostic Radiology.  

While preoperative breast MRI rarely changes prior decisions to perform mastectomy on women with biopsy-proven breast cancer, the extra imaging can reduce the odds of needing a second trip under the knife for patients undergoing breast-conserving surgery.

Annual screening mammography adds no value to women who are high risk for breast cancer and, as a matter of course, are already getting screened each year with breast MRI, according to a study conducted at the University of Toronto and published online June 6 in Radiology.

A third of breast-cancer patients undergoing preoperative mammography and ultrasound would be more accurately imaged for tumor size with breast MRI, according to a study published online April 13 in the Journal of Surgical Oncology. 

Via Radiology, based in Seattle, is the first in the Pacific Northwest to offer a new type of MRI screening for breast cancer patients.